Targacept (TRGT) Cash Flow Statement

Click line-items for a historical chart and %

Net income	-13.2M
Recognition of deferred revenue
Amortization of premium on marketable securities, net
Depreciation and amortization	328K
Stock-based compensation expense	505K
Excess tax benefits from stock-based compensation
Receivables from collaborations
Other current assets
Accounts payable, license fees payable and accrued expenses
Deferred license fee revenue	-329K
Net cash (used in) provided by operating activities
Purchase of investments in marketable securities	-13.4M
Proceeds from sale of investments in marketable securities
Purchase of property and equipment	-346K
Net cash used in investing activities
Principal payments on long-term debt
Proceeds from issuance of long-term debt
Proceeds from issuance of common stock, net	865K
Excess tax benefits from stock-based compensation
Net cash provided by financing activities
Net increase in cash and cash equivalents	-19.78M
Cash and cash equivalents at beginning of period	29.1M
Cash and cash equivalents at end of period	9.32M

Entities mentioned with TRGT

View All Entities